Moderna, Inc.
MRNA
Arpa Garay
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Arpa Garay
Moderna, Inc. reported in an 8-K filed December 12, 2023 that Arpa Garay was terminated as Chief Commercial Officer, effective December 8, 2023. The proxy statement of Moderna, Inc. reports total compensation of $7,676,152 for Arpa Garay in fiscal 2022, including a base salary of $458,462.
“On December 12, 2023, Moderna, Inc. (the “Company”) announced that following a restructuring of the Company’s commercial organization and reporting lines, Arpa Garay, the Company’s Chief Commercial Officer, will be departing the Company, and that effective as of December 8, 2023, Ms. Garay will no longer serve in that role or as an executive officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Moderna, Inc. (MRNA)
Source not stated
Start not stated–2023-12-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Moderna, Inc. (MRNA) | Chief Commercial Officer | $458,462 | $7,676,152 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.